Gjør som tusenvis av andre bokelskere
Abonner på vårt nyhetsbrev og få rabatter og inspirasjon til din neste leseopplevelse.
Ved å abonnere godtar du vår personvernerklæring.Du kan når som helst melde deg av våre nyhetsbrev.
"Commissioned papers were discussed at a public workshop held June 10-11, 2010, in Washington, D.C., and authors revised their papers after the workshop."--Publisher's website.
"Panel on Addressing the Challenges of Climate Change Through the Behavioral and Social Sciences, Committee on the Human Dimensions of Global Change, Division of Behavioral and Social Sciences and Education, National Research Council of the National Academies."
"Newborn screening samples are used to test more than 4 million infants each year for life-threatening diseases that are treatable if found at birth. These specimens also represent a potentially invaluable resource for public health and biomedical research. The IOM held a workshop to examine issues surrounding the use of residual specimens for translational research."
Authoring committees: Chinese Academy of Social Sciences, Indian National Science Academy, Indonesian Academy of Sciences, National Research Council of the U.S. National Academies, Science Council of Japan.
Report of the ad hoc committee based on an October 2007 workshop and two follow-up meetings.
"The Food and Drug Administration (FDA) is tasked with ensuring the safety and effectiveness of medicine. FDA's science base must be strong enough to make certain that regulatory decisions are based on the best scientific evidence. The IOM held a public workshop on February 26, 2010, to examine the state of regulatory science and to consider approaches for enhancing it."--Publisher's description.
"Sustainability science and technology"--Cover.
"Planning Committee for Food Supply and Aging Populations"--P. v.
Accompanying CD-ROM contains appendices D-M.
"The Food and Drug Administration (FDA) is responsible for assuring that medical devices are safe and effective before they go on the market. As part of its assessment of FDA's premarket clearance process for medical devices, the IOM held a workshop June 14-15 to discuss how to best balance patient safety and technological innovation. This document summarizes the workshop."--
"In cooperation with IAP: The Global Network of Science Academies, International Union of Biochemistry and Molecular Biology, International Union of Microbiological Societies, Polish Academy of Sciences."
Abonner på vårt nyhetsbrev og få rabatter og inspirasjon til din neste leseopplevelse.
Ved å abonnere godtar du vår personvernerklæring.